Navigation Links
Top 10 “Best Children’s Hospitals” Include 3 Pediatric Centers Offering SynCardia Total Artificial Heart

Tucson, Ariz. (PRWEB) June 26, 2012

SynCardia Systems, Inc., manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that U.S. News & World Report has named three pediatric centers that offer the SynCardia temporary Total Artificial Heart among the nation’s Top 10 “Best Children’s Hospitals” for Cardiology and Heart Surgery in its annual list. The Children’s Hospital of Philadelphia (CHOP) was ranked #2, Texas Children’s Hospital was ranked #3 and Cincinnati Children’s Hospital Medical Center was ranked #9.

In May 2011, Texas Children's became the first pediatric hospital in the world to implant the Total Artificial Heart. The patient, 17-year-old Jordan Merecka, was born with a "reversed" heart (dextrocardia) and his heart vessels backwards (corrected transposition of the great arteries). In August 2011, he became the first pediatric Total Artificial Heart patient to be discharged from the hospital using the Freedom® portable driver, the world’s first wearable power supply for the Total Artificial Heart. Jordan received his heart transplant on Oct. 20, 2011. This August, he will begin his first day of classes in the Maritime Systems Engineering program at Texas A&M.

“One of the most impressive things about the Total Artificial Heart is it can take the most ill patients who are in multi-system organ failure, reverse the process and recuperate these patients for whom other forms of mechanical therapy may fall short,” said Dr. David L.S. Morales, Jordan’s surgeon and the new chief of pediatric cardiothoracic surgery at Cincinnati Children’s. “The Total Artificial Heart has opened the flood gates in respect to the treatment possibilities for a quickly growing population of children in heart failure, including adolescents suffering from chronic rejection of their transplanted heart, end-stage heart failure accompanied by multiple congenital defects and a chronic failed Fontan circulation.”

In January 2012, CHOP became the first hospital to implant the Total Artificial Heart into a pediatric patient who was born with only one functional heart ventricle and was suffering from a failed Fontan procedure. The teenager was bridged to a transplant with the Total Artificial Heart in March 2012.

“Pediatric patients who have undergone multiple operations often have no surgical options remaining other than cardiac transplantation,” said Dr. J. William Gaynor, an attending cardiothoracic surgeon at CHOP. “When the SynCardia Total Artificial heart is compared to ventricular assist devices, there is simply no other device which offers the same improvement in cardiac output, the same flexibility for complex congenital heart disease and the same opportunity to improve the condition of these patients and their long-term survival.”

In March, Phoenix Children's Hospital bridged its first patient to transplant with the Total Artificial Heart. This marked three consecutive pediatric patients bridged to transplant with the Total Artificial Heart during a six-month period ending March 2012.

The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.

CAUTION – The Freedom® portable driver is an investigational device, limited by United States law to investigational use.

Like SynCardia on Facebook
Follow SynCardia on Twitter – @SynCardia
Connect with SynCardia on [LinkedIn

About the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, SynCardia's Total Artificial Heart is currently approved as a bridge to transplant for people dying from end-stage biventricular heart failure. There have been more than 1,000 implants of the Total Artificial Heart, accounting for more than 250 patient years of life.

Similar to a heart transplant, SynCardia's Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers and does not require expensive anti-rejection medication, which can cause subsequent complications. It is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through both ventricles. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.

SynCardia Ranked #20 Among World's 50 Most Innovative Companies

In March 2011, Fast Company magazine ranked SynCardia #20 in its annual list of the "World's 50 Most Innovative Companies" for "giving mobility to artificial heart recipients." Weighing 13.5 pounds, SynCardia's Freedom® portable driver is the world's first wearable driver designed to power the Total Artificial Heart both inside and outside the hospital. The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved  

Related biology technology :

1. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
2. Discovery Labs to Present AFECTAIR® Data at European Congress on Pediatric and Neonatal Ventilation
3. Two Top Biological Imaging Centers Offer Powerful Free Online Tool to Researchers, Educators, and Public
4. Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy
5. At-the-Market Offerings (ATM) of Life Sciences Companies Perform Well in Weak Follow-on Financing Environment of Third Quarter
6. iBio, Inc. Prices $10 Million Public Offering
7. Sequenom Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
8. Spherix Announces Registered Direct Offering of $1.15 Million
9. Neuralstem Announces Closing of $5.2-Million Registered Direct Offering
10. Elsevier Collaborates With Prophecy Healthcare to Enhance Its Staff Development Offerings for Healthcare Organizations
11. OncoSec Closes $7.75 Million Public Offering
Post Your Comments:
Related Image:
Top 10 “Best Children’s Hospitals” Include 3 Pediatric Centers Offering SynCardia Total Artificial Heart
(Date:10/12/2015)... ... 2015 , ... Dr. Carl Peck, MD, Chairman of NDA ... a Premier Expert consultant. NDA Partners Premier Experts are top tier consultants ... company's clients. Premier Experts collaborate to design and implement critical solutions to ...
(Date:10/11/2015)... ... October 11, 2015 , ... Intelligent Implant ... officially launched and multiple surgeries have been completed with this new posterior thoracolumbar ... Neuroscience & Spine Center of the Carolinas. The Revolution™ Spinal System pioneers ...
(Date:10/9/2015)... , Oct. 9, 2015 On October ... the Congressional Record her statement recognizing the third annual ... 11-17. IPAW is sponsored by the Plasma Protein ... is designed to:   , Raise global awareness ... plasma donors in saving and improving lives , ...
(Date:10/9/2015)...  DePuy Synthes Trauma* announced today the U.S. launch ... Technology**, the only pre-hydrated demineralized cancellous bone tissue matrix ... ankle, hand and wrist), including fusion, and for filling ... 2015 Orthopaedic Trauma Association (OTA) Annual Meeting. ... bone growth) and osteoinductive 2,3 (stimulates new bone ...
Breaking Biology Technology:
(Date:9/28/2015)... 28, 2015 Synaptics Inc. (NASDAQ: SYNA ... announced that Lenovo has selected Synaptics , Natural ... its latest smartphone, the Vibe P1. The new ... the device and provide swift access to applications and ... Natural ID FS4202 sensor solution utilizes AES256-bit encryption of ...
(Date:9/24/2015)... 2015  EyeLock LLC, a market leader of iris-based ... and latest technology in Booth #602 at next week,s ... EyeLock,s iris authentication technology provides an unprecedented ... making it the most proven way to authenticate one,s ... to deliver a fast and friendly user experience to ...
(Date:9/10/2015)... 2015 This report provides detailed descriptions of ... and emerging sensor types that will dominate in the ... of the wearable technology hype curve in the last ... common feature with all of them is the prominence ... most useful functions. Sensors collect data about the physical ...
Breaking Biology News(10 mins):